argenx SE (ARGX)
NASDAQ: ARGX · IEX Real-Time Price · USD
372.80
+4.20 (1.14%)
Apr 26, 2024, 4:00 PM EDT - Market closed
argenx SE Employees
argenx SE had 1,148 employees on December 31, 2023. The number of employees increased by 305 or 36.18% compared to the previous year.
Employees
1,148
Change (1Y)
305
Growth (1Y)
36.18%
Revenue / Employee
$34,391
Profits / Employee
-$285,572
Market Cap
22.16B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 1,148 | 305 | 36.18% |
Dec 31, 2022 | 843 | 193 | 29.69% |
Dec 31, 2021 | 650 | 314 | 93.45% |
Dec 31, 2020 | 336 | 148 | 78.72% |
Dec 31, 2019 | 188 | 83 | 79.05% |
Dec 31, 2018 | 105 | 32 | 43.84% |
Dec 31, 2017 | 73 | 15 | 25.86% |
Dec 31, 2016 | 58 | 17 | 41.46% |
Dec 31, 2015 | 41 | 9 | 28.13% |
Dec 31, 2014 | 32 | 10 | 45.45% |
Dec 31, 2013 | 22 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
Company Name | Employees |
---|---|
Baxter International | 60,000 |
Cardinal Health | 48,000 |
ICON PLC | 41,100 |
Align Technology | 21,610 |
Zimmer Biomet Holdings | 18,000 |
Molina Healthcare | 18,000 |
STERIS | 17,100 |
Illumina | 13,360 |
ARGX News
- 12 days ago - argenx Data Highlight Evidence that VYVGART and VYVGART Hytrulo Drive Transformative Outcomes for Patients with Debilitating Autoimmune Disease - GlobeNewsWire
- 4 weeks ago - argenx Advances Clinical Development of Efgartigimod in Primary Sjogren's Disease - GlobeNewsWire
- 4 weeks ago - argenx Announces Annual General Meeting of Shareholders on May 7, 2024 - GlobeNewsWire
- 4 weeks ago - argenx Announces Approval of VYVGART (efgartigimod alfa) in Japan for Adults with Primary Immune Thrombocytopenia - GlobeNewsWire
- 7 weeks ago - argenx Delivers on Promise to Transform Patient Expectations in Autoimmunity at American Academy of Neurology 2024 Annual Meeting - GlobeNewsWire
- 2 months ago - argenx Reports Full Year 2023 Financial Results and Provides Fourth Quarter Business Update - GlobeNewsWire
- 2 months ago - argenx to Present at Upcoming Investor Conferences - GlobeNewsWire
- 2 months ago - argenx to Report Full Year 2023 Financial Results and Fourth Quarter Business Update on February 29, 2024 - GlobeNewsWire